FasterCures’ Post

The Milken Institute believes the newly released US Food and Drug Administration draft guidance on Diversity Action Plans creates a pathway for diverse and inclusive clinical trials. Read our statement here: https://lnkd.in/eDNXpA4V We support many of the recommendations in the guidance and note key points for clarification and enforcement. “We look forward to working with the FDA to refine the guidance to maximize the full potential of the Diversity Action Plans,” said Esther Krofah, executive vice president of Health at the Milken Institute. “It is imperative that clinical trials, and thus access to potential treatments and interventions, reflect prevalence and incidence of US intended population, including communities of color and other historically underrepresented populations.” #clinicaltrials #healthequity

Read this Q&A interview by Clinical Trials Arena with Esther Krofah, executive vice president of Health at the Milken Institute, to learn about the newly released US Food and Drug Administration draft guidance on Diversity Action Plans for clinical trials, and considerations for sponsors and drug developers.

At the 27th Milken Institute Global Conference, FasterCures curated public sessions centered around this year's theme, "Shaping a Shared Future." The emerging key health trends were prevention, AI, early cancer detection, and creating more equitable clinical trials. Read this issue brief for more health trends from Global Conference: https://lnkd.in/g6JpgZCv

“We need to put humanity back into research,” said Yasmeen Long, director of FasterCures.    Long was invited to speak on a panel at the Ideagen “Future of…Summit” 2024 where she highlighted the work FasterCures is leading to create a more equitable health care ecosystem. Watch a recording of the full conversation here: https://lnkd.in/ePWQ3Cvh

Happening soon! On Wednesday, June 26, the White House will host a Clinical Trials Forum. All are invited to join the opening session via livestream from 10:00 – 11:00 am ET at https://lnkd.in/eEByJbpj

A new report by the Milken Institute, "Distance as an Obstacle to Clinical Trial Access: Who is Affected and Why It Matters" is part of a broader effort by FasterCures to increase access to and diversity in #clinicaltrials. We recently released "Toward a National Action Plan for Achieving Diversity in Clinical Trials" and launched Enabling Networks of Research Infrastructure for Community Health through Clinical Trials (ENRICH-CT), a multi-stakeholder initiative focused on driving dialogue and advancing practical solutions for ways the public and private sectors can support more infrastructure in the US for more inclusive clinical research.  Learn more in this news release: https://lnkd.in/gAChf73X

The Milken Institute is proud to be a HealthyNYC Champion. Sung Hee Choe, managing director of FasterCures, and Sabrina Spitaletta Johar, senior director of Public Health at the Milken Institute, attended a kick-off event last week with Dr. Ashwin Vasan, commissioner, NYC Department of Health and Mental Hygiene, and other leaders who are committed to supporting HealthyNYC goals to reduce the impact of the leading causes of death and inequity.   “We are pleased to join this initiative as a HealthyNYC Champion because we know partnership is critical to identifying and implementing practical solutions that prevent disease and achieve better health outcomes,” said Esther Krofah, executive vice president of Milken Institute Health in a press release for the campaign.    Learn more: https://lnkd.in/euEub-2W